May 2019 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2018/19 Invitation to Tender, dated 1 November 2018.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2018/19 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2022
CORRECTION to February 2019 tender notification: in bold and strikethrough
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
|
Chemical name |
Presentation; |
Current |
New |
Hospital supply brand |
DV Limit |
Date of subsidy change |
Sole Subsidised Supply date |
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
Note: This product will remain listed in Part II Section H of the Pharmaceutical Schedule; however, will not be under Hospital Sole Supply Status.
CORRECTION to April 2019 tender notification: in bold and strikethrough
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
|
Omeprazole |
Inj 40 mg ampoule with diluent, 5 glass ampoule pack |
$33.98 |
$33.98 |
Dr Reddy’s Omeprazole (Dr Reddy’s) |
1 July 2019 |
1 October |
|
Chemical name |
Presentation; |
Current |
New |
Sole supply brand |
Date of subsidy change |
Sole Subsidised Supply date |
|---|
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
|
Omeprazole |
Inj 40 mg ampoule with diluent, 5 glass ampoule pack |
$33.98 |
$33.98 |
Dr Reddy’s Omeprazole (Dr Reddy’s) |
1% |
1 July 2019 |
1 October |
|
Chemical name |
Presentation; |
Current |
New |
Hospital supply brand |
DV |
Listing date |
Hospital Supply Status date |
|---|
2018/19 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2022
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current |
New |
Sole supply brand |
Date of subsidy change |
Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
|
Cilazapril |
Tab 0.5 mg; 90 tablet, bottle pack |
$2.00 |
$2.09 |
Zapril |
1 July 2019 |
1 September 2019 |
2. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current |
New |
Sole supply brand (Supplier) |
Date of listing |
Sole Subsidised Supply date |
Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|
|
Amoxicillin |
Cap 250 mg; 500 capsule, blister pack |
$14.97 |
$22.50 |
Alphamox |
1 November 2019 |
1 April 2020 |
Apo-Amoxi (Apotex) |
|
Amoxicillin |
Cap 500 mg; 500 capsule, blister pack |
$16.75 |
$36.98 |
Alphamox |
1 November 2019 |
1 April 2020 |
Apo-Amoxi (Apotex) |
|
Azathioprine |
Tab 25 mg; 60 tablet, blister pack |
$9.66 per 100 tab |
$7.35 |
Azamun |
1 August 2019 |
1 January 2020 |
Imuran (Aspen) |
|
Azathioprine |
Tab 50 mg; 100 tablet, blister pack |
$10.58 |
$7.60 |
Azamun |
1 August 2019 |
1 January 2020 |
Imuran (Aspen) |
|
Cilazapril |
Tab 2.5 mg; 90 tablet, bottle pack |
$7.20 per 200 tab |
$4.80 |
Zapril |
1 September 2019* |
1 February 2020 |
Apo-Cilazapril (Apotex) |
|
Cilazapril |
Tab 5 mg; 90 tablet, bottle pack |
$12.00 per 200 tab |
$8.35 |
Zapril |
1 September 2019* |
1 February 2020 |
Apo-Cilazapril (Apotex) |
|
Compound electrolytes |
Powder for oral soln; 50 sachet pack (change in PSO from 10 sachets to 5 sachets from 1 April 2020) |
$2.30 per 10 sachet |
$9.77 |
Electral |
1 November 2019 |
1 April 2020 |
Enerlyte (Multichem) |
|
Dexamethasone phosphate |
Inj 4 mg per ml, 1 ml ampoule; 10 ampoule pack |
$14.19 |
$9.25 |
Dexamethasone Phosphate Panpharma |
1 February 2020 |
1 July 2020 |
Max Health (Max Health) |
|
Dexamethasone phosphate |
Inj 4 mg per ml, 2 ml ampoule; 10 ampoule pack |
$25.18 |
$16.37 |
Dexamethasone Phosphate Panpharma |
1 February 2020 |
1 July 2020 |
Max Health (Max Health) |
|
Paroxetine |
Tab 20 mg; 90 tablet, blister pack |
$4.02 |
$3.61 |
Loxamine |
1 October 2019 |
1 March 2020 |
Apo-Paroxetine (Apotex) |
|
Ropinirole hydrochloride |
Tab 0.25 mg; 84 tablet, bottle pack |
$2.78 per 100 tab |
$2.85 |
Ropin |
1 October 2019 |
1 March 2020 |
Apo-Ropinirole (Apotex) |
|
Ropinirole hydrochloride |
Tab 1 mg; 84 tablet, bottle pack |
$5.00 per 100 tab |
$3.95 |
Ropin |
1 October 2019 |
1 March 2020 |
Apo-Ropinirole (Apotex) |
|
Ropinirole hydrochloride |
Tab 2 mg, 84 tablet, bottle pack |
$7.72 per 100 tab |
$5.48 |
Ropin |
1 October 2019 |
1 March 2020 |
Apo-Ropinirole (Apotex) |
|
Ropinirole hydrochloride |
Tab 5 mg; 84 tablet, bottle pack |
$16.51 per 100 tab |
$12.50 |
Ropin |
1 October 2019 |
1 March 2020 |
Apo-Ropinirole (Apotex) |
|
Sertraline |
Tab 50 mg; 30 tablet, blister pack |
$3.05 per 90 tab |
$0.92 |
Setrona |
1 October 2019 |
1 March 2020 |
Arrow-Sertraline (Teva) |
|
Sertraline |
Tab 100 mg; 30 tablet, blister pack |
$5.25 per 90 tab |
$1.61 |
Setrone |
1 October 2019 |
1 March 2020 |
Arrow-Sertraline (Teva) |
|
Sunscreen, propietary |
Lotion; 200 g OP tube |
$5.10 |
$5.10 |
Marine Blue Ltion SPF 50+ |
1 October 2019 |
1 March 2020 |
Marine Blue Lotion SPF 50+ 100 g (Boucher and Muir) Hamilton Sunscreen (Valeant Pharmaceuticals) |
*Please note stock may not be available from 12 August, however a listing date of 1 September still stands.
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
3. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current |
New |
Hospital supply brand |
DV |
Date of subsidy change |
Hospital Supply Status date |
|---|---|---|---|---|---|---|---|
|
Cilazapril |
Tab 0.5 mg; 90 tablet, bottle pack |
$2.00 |
$2.09 |
Zapril |
1% |
1 July 2019 |
1 September 2019 |
4. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Hospital supply brand |
DV |
Listing date |
Hospital Supply Status date |
Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|---|
|
Amoxicillin |
Cap 250 mg; 500 capsule, blister pack |
$14.97 |
$22.50 |
Alphamox |
1% |
1 November 2019 |
1 April 2020 |
Apo-Amoxi (Apotex) |
|
Amoxicillin |
Cap 500 mg; 500 capsule, blister pack |
$16.75 |
$36.98 |
Alphamox |
1% |
1 November 2019 |
1 April 2020 |
Apo-Amoxi (Apotex) |
|
Azathioprine |
Tab 25 mg; 60 tablet, blister pack |
$9.66 per 100 tab |
$7.35 |
Azamun |
1% |
1 August 2019 |
1 January 2020 |
Imuran (Aspen) |
|
Azathioprine |
Tab 50 mg; 100 tablet, blister pack |
$10.58 |
$7.60 |
Azamun |
1% |
1 August 2019 |
1 January 2020 |
Imuran (Aspen) |
|
Cilazapril |
Tab 2.5 mg; 90 tablet, bottle pack |
$7.20 per 200 tab |
$4.80 |
Zapril |
1% |
1 September 2019* |
1 February 2020 |
Apo-Cilazapril (Apotex) |
|
Cilazapril |
Tab 5 mg; 90 tablet, bottle pack |
$12.00 per 200 tab |
$8.35 |
Zapril |
1% |
1 September 2019* |
1 February 2020 |
Apo-Cilazapril (Apotex) |
|
Compound electrolytes |
Powder for oral soln; 50 sachet pack |
$2.30 per 10 sachet |
$9.77 |
Electral |
1% |
1 November 2019 |
1 April 2020 |
Enerlyte (Multichem) |
|
Dexamethasone phosphate |
Inj 4 mg per ml, 1 ml ampoule; 10 ampoule pack |
$14.19 |
$9.25 |
Dexamethasone Phosphate Panpharma |
1% |
1 February 2020 |
1 July 2020 |
Max Health (Max Health) |
|
Dexamethasone phosphate |
Inj 4 mg per ml, 2 ml ampoule; 10 ampoule pack |
$25.18 |
$16.37 |
Dexamethasone Phosphate Panpharma |
1% |
1 February 2020 |
1 July 2020 |
Max Health (Max Health) |
|
Droperidol |
Inj 2.5 mg per ml, 1 ml ampoule, 10 ampoule pack |
$35.00 |
$30.95 |
Droleptan |
1% |
1 December 2019 |
1 May 2020 |
Droperidol Panpharma (Multichem) |
|
Iloprost |
Inj 50 mcg in 0.5 ml ampoule, 5 ampoule pack |
$380.00 |
$305.00 |
Clinect |
1% |
1 August 2019 |
1 January 2020 |
Ilomedin (Bayer) |
|
Paroxetine |
Tab 20 mg; 90 tablet, blister pack |
$4.02 |
$3.61 |
Loxamine |
1% |
1 October 2019 |
1 March 2020 |
Apo-Paroxetine (Apotex) |
|
Propofol |
Inj 10 mg per ml, 20 ml vial, 5 vial pack |
$5.27 |
$4.35 |
Fresofol 1% MCT/LCT |
10% |
1 July 2019 |
1 December 2019 |
Provive MCT-LCT 1% (Baxter) |
|
Ropinirole hydrochloride |
Tab 0.25 mg; 84 tablet, bottle pack |
$2.78 per 100 tab |
$2.85 |
Ropin |
1% |
1 October 2019 |
1 March 2020 |
Apo-Ropinirole (Apotex) |
|
Ropinirole hydrochloride |
Tab 1 mg; 84 tablet, bottle pack |
$5.00 per 100 tab |
$3.95 |
Ropin |
1% |
1 October 2019 |
1 March 2020 |
Apo-Ropinirole (Apotex) |
|
Ropinirole hydrochloride |
Tab 2 mg, 84 tablet, bottle pack |
$7.72 per 100 tab |
$5.48 |
Ropin |
1% |
1 October 2019 |
1 March 2020 |
Apo-Ropinirole (Apotex) |
|
Ropinirole hydrochloride |
Tab 5 mg; 84 tablet, bottle pack |
$16.51 per 100 tab |
$12.50 |
Ropin |
1% |
1 October 2019 |
1 March 2020 |
Apo-Ropinirole (Apotex) |
|
Sertraline |
Tab 50 mg; 30 tablet, blister pack |
$3.05 per 90 tab |
$0.92 |
Setrona |
1% |
1 October 2019 |
1 March 2020 |
Arrow-Sertraline (Teva) |
|
Sertraline |
Tab 100 mg; 30 tablet, blister pack |
$5.25 per 90 tab |
$1.61 |
Setrone |
1% |
1 October 2019 |
1 March 2020 |
Arrow-Sertraline (Teva) |
|
Sunscreen, propietary |
Ltn; 200 g tube |
$5.10 |
$5.10 |
Marine Blue Lotion SPF 50+ (Boucher and Muir) |
1% |
1 October 2019 |
1 March 2020 |
Marine Blue Lotion SPF 50+ 100 g (Boucher and Muir) Cream – ‘any brand’ |
*Please note stock may not be available from 12 August, however a listing date of 1 September still stands.
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in:
- the 2018/19 Invitation to Tender, dated 1 November 2018
|
Chemical name |
Line item |
|---|---|
|
Aluminium hydroxide |
Tab 600 mg |
|
Amisulpride |
Oral liq 100 mg per ml |
|
Betamethasone |
Crm 0.05% (pack size 30 g and under) |
|
Betamethasone |
Oint 0.05% (pack size 30 g and under) |
|
Brimonidine Tartrate with |
Eye drops 0.2% with timolol maleate |
|
Bupivacaine hydrochloride |
Inj 0.625 mg with fentanyl 2 mcg per |
|
Bupivacaine hydrochloride |
Inj 1.25 mg with fentanyl 2 mcg per ml, |
|
Bupivacaine hydrochloride |
Inj 1.25 mg with fentanyl 2 mcg per ml, |
|
Cefoxitin Sodium |
Inj 1 g |
|
Desmopressin |
Tab 200 mcg |
|
Desmopressin |
Tab 100 mcg |
|
Desmopressin |
Inj 15 mcg per ml, 1 ml |
|
Desmopressin |
Nasal drops 100 mcg per ml |
|
Desmopressin |
Inj 4 mcg per ml, 1 ml |
|
Disodium edetate |
Inj 150 mg per ml, 20 ml - 100 ml |
|
Dosulepin [Dothiepin] |
Tab 75 mg |
|
Dosulepin [Dothiepin] |
Cap 25 mg |
|
Fluconazole |
Inj 2 mg per ml |
|
Fluorometholone |
Eye drops 0.1% |
|
Hyaluronidase |
Inj 1,500 iu per ml |
|
Hyoscine (Scopolamine) |
Patches, 1.5 mg |
|
Levosimendan |
Inj 2.5 mg per ml, 10 ml |
|
Lithium Carbonate |
Tab 250 mg |
|
Lithium carbonate |
Cap 250 mg |
|
Lithium Carbonate |
Tab 400 mg |
|
Lormetazepam |
Tab 1 mg |
|
Maprotiline Hydrochloride |
Tab 25 mg |
|
Maprotiline Hydrochloride |
Tab 75 mg |
|
Methylprednisolone Acetate |
Inj 40 mg per ml with lignocaine 1 ml |
|
Methylprednisolone Acetate |
Inj 40 mg per ml with lignocaine 2 ml |
|
Mianserin hydrochloride |
Tab 30 mg |
|
Morphine tartrate |
Inj 80 mg per ml, 1.5 ml |
|
Nitrazepam |
Tab 5 mg |
|
Noradrenaline |
Inj 0.06 mg per ml, 100 ml bag |
|
Noradrenaline |
Inj 0.12 mg per ml, 50 ml syringe |
|
Noradrenaline |
Inj 1 mg per ml, 100 ml bag |
|
Oestradiol |
Tab 1 mg |
|
Oestradiol |
Tab 2 mg |
|
Omeprazole |
Powder |
|
Paraffin |
Enema 133 ml |
|
Phenothrin |
Shampoo 0.5% |
|
Polyvinyl alcohol |
Eye drops 1.4% |
|
Polyvinyl alcohol |
Eye drops 3% |
|
Pyridoxine hydrochloride |
Inj 100 mg per ml, 1 ml |
|
Pyridoxine hydrochloride |
Inj 100 mg per ml, 30 ml |
|
Roxithromycin |
Dispersible tab - 50 mg |
|
Sodium alginate with |
Powder for oral soln 225 mg with magnesium alginate 87.5 mg, sachet |
|
Dosiunm alginate with |
Oral liq 500 mg with sodium |
|
Sodium fusidate [fusidic |
Eye drops 1% |
|
Sodium phosphate with |
Oral liq 16.4% with phosphoric acid |
|
Sodium Phosphate with |
Enema 10% with phosphoric acid |
|
Tolterodone tartrate |
Tab 1 mg |
|
Tolterodone tartrate |
Tab 2 mg |
|
Triclosan |
Soln 1% |
|
Vecuronium |
Inj 10 mg |
|
Zidovudine |
Inj 10 mg per ml, 20 ml vial |
|
Zidovudine |
Cap 100 mg |
|
Zidovudine |
Oral liq 10 mg per ml |
For products included in the 2016/17, 2017/18 and 2018/19 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.